CarolASatlerMDPhD FACC FAHA FAAP

Pediatric Cardiac Genetics

Physician

Dr. Satler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Cardiology, 1989 - 1996
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1986 - 1989
Case Western Reserve University School of MedicineClass of 1986

PubMed

3 citations
Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design.
Raymond L Benza, Veronica Franco, Mandar A Aras, Leslie Spikes, Daniel Grinnan
Respiratory Research. 2022-12-17
14 citations
Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial.
Stephan Rosenkranz, Jeremy Feldman, Vallerie V. McLaughlin, Franz Rischard, Tobias J. Lange
The Lancet. Respiratory Medicine. 2021-08-20
48 citations
Monitoring for Pulmonary Hypertension Following Pulmonary Embolism: The INFORM Study
Victor F. Tapson, David Platt, Fang Xia, S Teal, Margarita de la Orden
The American Journal of Medicine. 2016-09-01

Insilico Plans Pivotal Trial for AI-Based IPF CandidateNovember 12th, 2024
Insilico Announces Positive Topline Results for IPF TreatmentNovember 12th, 2024
Insilico Medicine Announces Positive Topline Results of ISM001-055 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) Developed Using Generative AINovember 12th, 2024
Join now to see all